BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12776197)

  • 1. Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis.
    Li YJ; Song R; Korkola JE; Archer MC; Ben-David Y
    Oncogene; 2003 May; 22(22):3452-62. PubMed ID: 12776197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-24 induces expression of beta4 integrin but suppresses anchorage-independent growth of rat mammary tumor cells by a mechanism that is independent of beta4.
    Xuan W; Li YJ; Liu G; Ben-David Y; Archer MC
    Mol Cancer Res; 2009 Mar; 7(3):433-42. PubMed ID: 19258414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.
    Wang Y; Thakur A; Sun Y; Wu J; Biliran H; Bollig A; Liao DJ
    Cancer Res; 2007 Apr; 67(8):3698-707. PubMed ID: 17440082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of anchorage-independent cell growth, adhesion, and cyclin D1 gene expression by a dominant negative mutant of a tyrosine phosphatase.
    Mitra SK; Swarup G
    Exp Cell Res; 2001 Oct; 270(1):32-44. PubMed ID: 11597125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
    Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J
    Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
    Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B
    Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of transforming growth factors in human breast cancer cells.
    Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR
    Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of ras oncogene-induced gene expression and anchorage-independent growth in a series of somatic cell mutants.
    Feinleib JL; Krauss RS
    Mol Carcinog; 1996 Jul; 16(3):139-48. PubMed ID: 8688149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis.
    Haag JD; Hsu LC; Newton MA; Gould MN
    Mol Carcinog; 1996 Nov; 17(3):134-43. PubMed ID: 8944073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming the activity of mammary carcinoma suppressor gene in Copenhagen rats by v-H-ras oncogene transfer into mammary epithelial cells in situ.
    Wang B; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
    Cancer Res; 1991 Oct; 51(19):5298-303. PubMed ID: 1913652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative genomics of susceptibility to mammary carcinogenesis among inbred rat strains: role of reduced prolactin signaling in resistance of the Copenhagen strain.
    Ren X; Zhang X; Kim AS; Mikheev AM; Fang M; Sullivan RC; Bumgarner RE; Zarbl H
    Carcinogenesis; 2008 Jan; 29(1):177-85. PubMed ID: 17916903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of cyclin D1 and the Rb tumor suppressor gene in c-K-ras transformed rat enterocytes.
    Arber N; Sutter T; Miyake M; Kahn SM; Venkatraj VS; Sobrino A; Warburton D; Holt PR; Weinstein IB
    Oncogene; 1996 May; 12(9):1903-8. PubMed ID: 8649851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional transformation of rat embryo fibroblast cells by a cyclin D1-cdk4 fusion gene.
    Rao RN; Stamm NB; Otto K; Kovacevic S; Watkins SA; Rutherford P; Lemke S; Cocke K; Beckmann RP; Houck K; Johnson D; Skidmore BJ
    Oncogene; 1999 Nov; 18(46):6343-56. PubMed ID: 10597234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma induction following direct in situ transfer of v-Ha-ras into rat mammary epithelial cells using replication-defective retrovirus vectors.
    Wang BC; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
    Cancer Res; 1991 May; 51(10):2642-8. PubMed ID: 2021942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 expression during rat mammary tumor development and its potential role in the resistance of the Copenhagen rat.
    Korkola JE; Wood GA; Archer MC
    Breast Cancer Res; 1999; 1(1):88-94. PubMed ID: 11056683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of cyclin DI contributes to malignant properties of esophageal tumor cells by increasing VEGF production and decreasing Fas expression.
    Shintani M; Okazaki A; Masuda T; Kawada M; Ishizuka M; Doki Y; Weinstein IB; Imoto M
    Anticancer Res; 2002; 22(2A):639-47. PubMed ID: 12014632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of a Ha-ras oncogene into rat liver epithelial cells and parenchymal hepatocytes confers resistance to the growth inhibitory effects of TGF-beta.
    Houck KA; Michalopoulos GK; Strom SC
    Oncogene; 1989 Jan; 4(1):19-25. PubMed ID: 2783773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of hormone-dependent adenocarcinoma cells to hormone-independent spindle carcinoma cells in vitro in a clonal spontaneous rat mammary tumor cell line.
    Nakanishi H; Taylor RM; Chrest FJ; Masui T; Utsumi K; Tatematsu M; Passaniti A
    Cancer Res; 1995 Jan; 55(2):399-407. PubMed ID: 7529136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.
    Lovec H; Sewing A; Lucibello FC; Müller R; Möröy T
    Oncogene; 1994 Jan; 9(1):323-6. PubMed ID: 8302597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.